Payment overview · 2025
General Payments
$108.09
5 reported records · 3 companies
Healthcare provider profile · identity verified
Laurence M Adams, MD
Allopathic & Osteopathic Physicians|Family Medicine · ZIONSVILLE, IN · NPI 1508961475
Verified facts
What the public records show
CMS Open Payments records show Laurence M Adams, MD received $108.09 in general payments during 2025 across 5 reported records.
Dexcom, Inc. accounted for 41.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $44.60 | 41.3% | 2 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $43.12 | 39.9% | 2 | 2025 |
| Corcept Therapeutics | Unresolved — no canonical attribution shown | $20.37 | 18.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $108.09 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $44.60 | 2 | 2025 |
Source payment records
|
|||||
| PROCLAIM Normalized: proclaim |
Device | Abbott Laboratories | $22.31 | 1 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $20.81 | 1 | 2025 |
Source payment records
|
|||||
| Korlym Normalized: korlym |
Drug | Corcept Therapeutics | $20.37 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 981 | 277 |
| Amlodipine Besylate | Amlodipine Besylate | 593 | 166 |
| Levothyroxine Sodium | Levothyroxine Sodium | 412 | 106 |
| Losartan Potassium | Losartan Potassium | 409 | 127 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 333 | 102 |
| Indapamide | Indapamide | 243 | 77 |
| Metformin Hcl | Metformin Hcl | 238 | 65 |
| Benazepril Hcl | Benazepril Hcl | 206 | 58 |
| Lisinopril | Lisinopril | 174 | 52 |
| Metoprolol Succinate | Metoprolol Succinate | 170 | 51 |
| Alendronate Sodium | Alendronate Sodium | 169 | 48 |
| Tamsulosin Hcl | Tamsulosin Hcl | 164 | 46 |
| Glipizide Er | Glipizide | 161 | 45 |
| Chlorthalidone | Chlorthalidone | 157 | 50 |
| Escitalopram Oxalate | Escitalopram Oxalate | 149 | 49 |
| Allopurinol | Allopurinol | 141 | 40 |
| Telmisartan | Telmisartan | 136 | 36 |
| Omeprazole | Omeprazole | 133 | 47 |
| Pantoprazole Sodium | Pantoprazole Sodium | 132 | 33 |
| Trazodone Hcl | Trazodone Hcl | 131 | 34 |
| Jardiance | Empagliflozin | 122 | 25 |
| Simvastatin | Simvastatin | 122 | 36 |
| Hydrochlorothiazide | Hydrochlorothiazide | 116 | 36 |
| Duloxetine Hcl | Duloxetine Hcl | 113 | 24 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 111 | 24 |
| Montelukast Sodium | Montelukast Sodium | 110 | 31 |
| Trulicity | Dulaglutide | 109 | 17 |
| Ezetimibe | Ezetimibe | 107 | 32 |
| Gabapentin | Gabapentin | 106 | 32 |
| Carvedilol | Carvedilol | 100 | 29 |
| Eliquis | Apixaban | 93 | 26 |
| Pravastatin Sodium | Pravastatin Sodium | 90 | 26 |
| Bupropion Xl | Bupropion Hcl | 84 | 23 |
| Fluoxetine Hcl | Fluoxetine Hcl | 84 | 17 |
| Sertraline Hcl | Sertraline Hcl | 84 | 21 |
| Ozempic | Semaglutide | 83 | 12 |
| Irbesartan | Irbesartan | 81 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 78 | 25 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 75 | 34 |
| Synthroid | Levothyroxine Sodium | 73 | 20 |
| Prednisone | Prednisone | 70 | 60 |
| Furosemide | Furosemide | 68 | 24 |
| Metoprolol Tartrate | Metoprolol Tartrate | 68 | 20 |
| Spironolactone | Spironolactone | 68 | 23 |
| Mounjaro | Tirzepatide | 60 | 13 |
| Clonazepam | Clonazepam | 59 | 11 |
| Potassium Chloride | Potassium Chloride | 59 | 20 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 58 | 16 |
| Meloxicam | Meloxicam | 57 | 21 |
| Valsartan | Valsartan | 56 | 19 |
| Alprazolam | Alprazolam | 55 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 55 | 16 |
| Clopidogrel | Clopidogrel Bisulfate | 54 | 18 |
| Doxazosin Mesylate | Doxazosin Mesylate | 52 | 17 |
| Famotidine | Famotidine | 52 | 20 |
| Mirtazapine | Mirtazapine | 49 | 11 |
| Cephalexin | Cephalexin | 48 | 38 |
| Verapamil Er | Verapamil Hcl | 43 | 11 |
| Xarelto | Rivaroxaban | 43 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 42 | 15 |
| Buspirone Hcl | Buspirone Hcl | 41 | 11 |
| Myrbetriq | Mirabegron | 40 | 13 |
| Donepezil Hcl | Donepezil Hcl | 39 | 13 |
| Nebivolol Hcl | Nebivolol Hcl | 39 | 13 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 39 | suppressed |
| Atenolol | Atenolol | 36 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 35 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 35 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 35 | 13 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 34 | 34 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 34 | 30 |
| Bupropion Hcl Sr | Bupropion Hcl | 33 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 33 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 32 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 31 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 28 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 28 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 28 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 28 | suppressed |
| Glipizide | Glipizide | 27 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 27 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 27 | 21 |
| Invokana | Canagliflozin | 26 | suppressed |
| Linzess | Linaclotide | 26 | suppressed |
| Acyclovir | Acyclovir | 25 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 25 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 25 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 24 | 15 |
| Memantine Hcl | Memantine Hcl | 24 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 24 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 23 | suppressed |
| Finasteride | Finasteride | 23 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 23 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 23 | 18 |
| Celecoxib | Celecoxib | 22 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 22 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Klor-Con M20 | Potassium Chloride | 21 | suppressed |
| Primidone | Primidone | 21 | 12 |
| Torsemide | Torsemide | 21 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 20 | 20 |
| Vascepa | Icosapent Ethyl | 20 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 20 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 19 | suppressed |
| Levemir | Insulin Detemir | 19 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 19 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 19 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 18 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 18 | 16 |
| Pregabalin | Pregabalin | 18 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 18 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 18 | suppressed |
| Azithromycin | Azithromycin | 17 | 14 |
| Breo Ellipta | Fluticasone/Vilanterol | 17 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 17 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 17 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 16 | suppressed |
| Fluconazole | Fluconazole | 16 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 16 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 16 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 15 | suppressed |
| Nifedipine Er | Nifedipine | 15 | suppressed |
| Ramipril | Ramipril | 15 | suppressed |
| Tenivac | Tetanus-Diphtheria Toxoids/Pf | 15 | 15 |
| Aripiprazole | Aripiprazole | 14 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 13 |
| Dexlansoprazole Dr | Dexlansoprazole | 14 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 14 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 14 | 11 |
| Januvia | Sitagliptin Phosphate | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 13 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | 11 |
| Olanzapine | Olanzapine | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $108.09 · 5 records | Dexcom, Inc. | Dexcom G6 Transmitter, FREESTYLE LIBRE 3, Korlym, PROCLAIM | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error